Australia markets open in 12 minutes

TheraVet SA (ALVET.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
0.7320-0.0480 (-6.15%)
At close: 05:35PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 2.51M
Enterprise value 1.75M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.07
Price/book (mrq)0.38
Enterprise value/revenue 1.44
Enterprise value/EBITDA -2.72

Trading information

Stock price history

Beta (5Y monthly) -0.26
52-week change 3-72.54%
S&P500 52-week change 321.61%
52-week high 32.9900
52-week low 30.7000
50-day moving average 31.0146
200-day moving average 31.2832

Share statistics

Avg vol (3-month) 310.27k
Avg vol (10-day) 312.69k
Shares outstanding 53.22M
Implied shares outstanding 63.26M
Float 8N/A
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 June 2023

Profitability

Profit margin -156.99%
Operating margin (ttm)-216.20%

Management effectiveness

Return on assets (ttm)-18.70%
Return on equity (ttm)-26.67%

Income statement

Revenue (ttm)1.3M
Revenue per share (ttm)0.40
Quarterly revenue growth (yoy)-33.20%
Gross profit (ttm)N/A
EBITDA -2.21M
Net income avi to common (ttm)-2.04M
Diluted EPS (ttm)-0.6500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.75M
Total cash per share (mrq)0.54
Total debt (mrq)990.97k
Total debt/equity (mrq)15.01%
Current ratio (mrq)4.20
Book value per share (mrq)2.05

Cash flow statement

Operating cash flow (ttm)-337.31k
Levered free cash flow (ttm)-1.27M